Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Varusca, Brusegan"'
Autor:
Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga
Publikováno v:
Bleeding, Thrombosis and Vascular Biology, Vol 2, Iss 2 (2023)
A syndrome occurring after adenoviral vector anti-SARS-CoV-2 vaccination, characterized by thrombocytopenia, venous thrombosis, and circulating anti-PF4 antibodies, known as vaccine-induced immune thrombotic thrombocytopenia (VITT), is well described
Externí odkaz:
https://doaj.org/article/81b15c434ca04a57ad38affcbd9e5ba6
Autor:
Kyriakoulis, Kg, Dimakakos, E, Kyriakoulis, Ig, Catalano, M, Spyropoulos, Ac, Schulman, S, Douketis, J, Falanga, A, Maraveyas, A, Olinic, Dm, Belch, J, Gerotziafas, G, Syrigos, K, Kollias, A, Darko Antic, Aleš, Blinc, Francesco, Boccardo, Marianne, Brodmann, Varusca, Brusegan, Alexandra, Canedo, Denisa, Čelovská, Benilde, Cosmi, DE MARCHI, Sergio, Gabriel, Dimitrov, Katalin, Farkas, Anders, Gottsäter, Christian, Heiss, Oguz, Karahan, Endre, Kolossváry, Matija, Kozak, Abraham, Kroon, Gianfranco, Lessiani, Aaron, Liew, George, Marakomichelakis, Peter, Marschang, Lucia, Mazzolai, Nikolaos-Georgios, Papageorgiou, Sergio, Pillon, Pavel, Poredos, Dusan, Suput, Marc, Righini, Gerit-Holger, Schernthaner, Aleksander, Sieroń, Jonas, Spaak, Muriel, Sprynger, Agata, Stanek, Daniel, Staub, Igor, Stojkovski, Adriana, Visonà, Dragan, Vasic, Jean-Claude, Wautrecht, Andrea, Willfort-Ehringer, Isabelle, Durand-Zaleski, Pecsvarady, Zsolt
Publikováno v:
Journal of clinical medicine. 11(20)
Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in the outpatient setting. Pharmacologic thromboprophylaxis has been shown to of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9223cc2250471e1f5411cb9f79f16a2
https://pubmed.ncbi.nlm.nih.gov/36294316
https://pubmed.ncbi.nlm.nih.gov/36294316
Publikováno v:
Pharmaceuticals, Vol 3, Iss 1, Pp 1-9 (2010)
We have studied the effects of add-on spironolactone treatment (100 mg/day) in 11 patients with idiopathic membranous nephropathy (IMN) and > 3 gm proteinuria/day despite angiotensin converting enzyme (ACE) inhibitor therapy titrated to a systolic/di
Externí odkaz:
https://doaj.org/article/397728871fe240ccbba706cac0f2cd77
Autor:
Anelja Parvanova Ilieva, Antonio Bossi, Piero Ruggenenti, Alessandro Roberto Dodesini, Anna Fassi, Roberto Trevisan, Flavio Gaspari, Ilian Iliev, Giulia Gherardi, Annalisa Perna, Nadia Rubis, Giuseppe Remuzzi, Varusca Brusegan, Bogdan Ene-Iordache, Federica Arnoldi, Simona Bruno, Maria Ganeva
Publikováno v:
The New England journal of medicine. 351(19)
BACKGROUND: The multicenter double-blind, randomized Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) was designed to assess whether angiotensin-converting-enzyme inhibitors and non-dihydropyridine calcium-channel blockers, alone or in com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28e52d5de967a9938affa3f9b82b4268
https://pubmed.ncbi.nlm.nih.gov/15981445
https://pubmed.ncbi.nlm.nih.gov/15981445
Autor:
Varusca Brusegan, Piero Ruggenenti, Mauro Abbate, Claudia Filippi, Carlos Chiurchiu, Annalisa Perna, Giuseppe Remuzzi
Publikováno v:
Journal of the American Society of Nephrology : JASN. 14(7)
Currently available monoclonal antibodies against the B cell surface antigen CD20 have been employed to explore whether specific inhibition of B cells may help improve the outcome of idiopathic membranous nephropathy (IMN) and may avoid the side effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6248bce5452cd96b5da085934ecd16b7
https://pubmed.ncbi.nlm.nih.gov/12819245
https://pubmed.ncbi.nlm.nih.gov/12819245